Chief Commercial Officer
Jonathan Hee, Aries Pharmaceutical, Inc.’s Chief Commercial Officer, is an executive leader specializing in establishing and scaling commercial operations to successfully launch new biopharmaceutical companies and products. Mr. Hee has helped create two multi-billion dollar companies in the biopharmaceutical industry, taking them from pre-commercial planning to commercial build out, product launch and lifecycle management. Prior to joining Aries he was a Principal with L.A.S. Partners, LLC a consulting firm focused on helping biopharmaceutical companies commercialize their products. As Vice President, Commercial Affairs at Santarus from 2004 – 2014, Mr. Hee commercialized products for the gastrointestinal disease, diabetes and other specialty markets until the sale of Santarus for $2.6B. Prior to Santarus, Mr. Hee worked with Agouron Pharmaceuticals, Inc., from 1995-2003, in Sales and Marketing leadership roles at this HIV and oncology biopharmaceutical company and ultimately led the commercial transition efforts following a $2.1B acquisition by Pfizer. Before joining Agouron, Mr. Hee was with Gensia, Inc., a cardiovascular and multi-source injectable drug company, where he held roles in Corporate Development, Marketing and Market Planning. He started his career with Atlantic Richfield Company (ARCO), working in Alaska and California, as a Senior Project Engineer. Mr. Hee holds an M.B.A. from Harvard University and a B.S. in Chemical Engineering from Stanford University.